Pages that link to "Q34984098"
Jump to navigation
Jump to search
The following pages link to Role of liver biopsy in management of chronic hepatitis C: a systematic review (Q34984098):
Displaying 50 items.
- Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies (Q22305832) (← links)
- Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C (Q24563264) (← links)
- Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest) (Q24802436) (← links)
- Four-dimensional flow magnetic resonance imaging in cirrhosis (Q26769606) (← links)
- Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage (Q26773289) (← links)
- Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B (Q26777916) (← links)
- Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections (Q28070280) (← links)
- Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C (Q28484313) (← links)
- Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. (Q30422199) (← links)
- Ultrasound in chronic liver disease (Q30432218) (← links)
- Invasive and non-invasive diagnosis of cirrhosis and portal hypertension (Q30439743) (← links)
- Liver elastography, comments on EFSUMB elastography guidelines 2013. (Q30448132) (← links)
- Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis (Q30470750) (← links)
- How efficient is acoustic radiation force impulse elastography for the evaluation of liver stiffness? (Q30472901) (← links)
- Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis? (Q30474480) (← links)
- Advanced MRI methods for assessment of chronic liver disease (Q30478601) (← links)
- Meta-analyses of FibroTest diagnostic value in chronic liver disease (Q33302708) (← links)
- Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy (Q33866383) (← links)
- The Role of Serum Biomarkers in Predicting Fibrosis Progression in Pediatric and Adult Hepatitis C Virus Chronic Infection (Q33999294) (← links)
- Liver biopsy for histological assessment: The case in favor (Q34469014) (← links)
- Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children (Q34551475) (← links)
- FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy (Q34686484) (← links)
- Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link (Q34792158) (← links)
- Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B. (Q34892910) (← links)
- Hepatitis infection in the treatment of opioid dependence and abuse. (Q35389163) (← links)
- "Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C. (Q35575885) (← links)
- Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus (Q35715916) (← links)
- Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease (Q36643026) (← links)
- Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C. (Q36812170) (← links)
- Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection. (Q37135387) (← links)
- Why, who and how should perform liver biopsy in chronic liver diseases. (Q37182969) (← links)
- Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection (Q37222778) (← links)
- Carbohydrate 19.9 antigen serum levels in liver disease. (Q37299982) (← links)
- Assessment of liver fibrosis: noninvasive means (Q37536973) (← links)
- An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients. (Q37626958) (← links)
- Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic (Q37825556) (← links)
- What is expected from the pathologist in the diagnosis of viral hepatitis? (Q37848125) (← links)
- Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index (Q41013952) (← links)
- Mini-laparoscopy in the endoscopy unit: Safety and outcomes in over one thousand patients (Q41960527) (← links)
- An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis (Q41970506) (← links)
- Non-biopsy methods to determine hepatic fibrosis. (Q42160967) (← links)
- Clinical Utility of Biomarkers of Liver Fibrosis (Q42196088) (← links)
- Applicability and variability of liver stiffness measurements according to probe position (Q42547916) (← links)
- Assessing liver fibrosis with serum marker models (Q42734827) (← links)
- Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C. (Q42982413) (← links)
- Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus (Q42999261) (← links)
- Ultrasonographic and biochemical parameters in the non-invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis (Q45423313) (← links)
- Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection. (Q46675145) (← links)
- Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis. (Q52699064) (← links)
- MR elastography for noninvasive assessment of hepatic fibrosis: Experience from a tertiary center in asia (Q53697565) (← links)